Peroxisome proliferator-activated receptor γ and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles
Open Access
- 1 January 2008
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 99 (01) , 86-95
- https://doi.org/10.1160/th07-05-0328
Abstract
Peroxisome proliferator-activated receptor γ (PPARγ) and its ligands are important regulators of lipid metabolism, inflammation, and diabetes. We previously demonstrated that anucleate human platelets express the transcription factor PPARγ and that PPARγ ligands blunt platelet activation. To further understand the nature of PPARγ in platelets, we determined the platelet PPARγ isoform(s) and investigated the fate of PPARγ following platelet activation. Our studies demonstrated that human platelets contain only the PPARγ1 isoform and after activation with thrombin, TRAP, ADP or collagen PPARγ is released from internal stores. PPARγ release was blocked by a cytoskeleton inhibitor, Latrunculin A. Platelet-released PPARγ was complexed with the retinoid X receptor (RXR) and retained its ability to bind DNA. Interestingly, the released PPARγ and RXR were microparticle associated and the released PPARγ/RXR complex retained DNA-binding ability. Additionally, a monocytic cell line, THP-1, is capable of internalizing PMPs. Further investigation following treatment of these cells with the PPARγ agonist, rosiglitazone and PMPs revealed a possible transcellular mechanism to attenuate THP-1 activation. These new findings are the first to demonstrate transcription factor release from platelets, revealing the complex spectrum of proteins expressed and expelled from platelets, and suggests that platelet PPARγ has an undiscovered role in human biology.Keywords
This publication has 48 references indexed in Scilit:
- PPARγ1 attenuates cytosol to membrane translocation of PKCα to desensitize monocytes/macrophagesThe Journal of cell biology, 2007
- Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human plateletsBlood, 2007
- Activated Human T Lymphocytes Express Cyclooxygenase-2 and Produce Proadipogenic Prostaglandins that Drive Human Orbital Fibroblast Differentiation to AdipocytesThe American Journal of Pathology, 2006
- Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trialThe Lancet, 2006
- Differential mechanisms of microparticle transfer toB cells and monocytes: anti‐inflammatory propertiesof microparticlesEuropean Journal of Immunology, 2006
- A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γNature, 2005
- The PPAR-γ activator, Rosiglitazone, inhibits actin polymerisation in monocytes: Involvement of Akt and intracellular calciumBiochemical and Biophysical Research Communications, 2005
- Soluble CD40L in peripheral artery diseaseThrombosis and Haemostasis, 2005
- Human B Lymphocytes and B Lymphomas Express PPAR-γ and Are Killed by PPAR-γ AgonistsClinical Immunology, 2002
- Ligand-induced stabilization of PPARγ monitored by NMR spectroscopy: implications for nuclear receptor activationJournal of Molecular Biology, 2000